-+ 0.00%
-+ 0.00%
-+ 0.00%

ARDELYX COMPLETES ENROLLMENT IN PHASE 3 ACCEL CLINICAL TRIAL OF IBSRELA® (TENAPANOR) IN ADULTS WITH CHRONIC IDIOPATHIC CONSTIPATION

Reuters·11/03/2026 13:00:02

Please log in to view news